John T Pelton

Title: John T. Pelton: Innovator in Neuropharmaceuticals

Introduction

John T. Pelton is a notable inventor based in Tucson, AZ, who has made significant contributions to the field of neuropharmaceuticals. His work primarily focuses on the development of novel compounds that interact with the mu opioid receptor, which is crucial for pain management and therapeutic applications.

Latest Patents

Pelton holds a patent for "Cyclic polypeptides having mu-receptor specificity." This patent discloses novel compounds capable of binding with enhanced specificity to the mu opioid receptor. The compounds are analogs of somatostatin and have a specific chemical formula that allows for their unique functionality.

Career Highlights

John T. Pelton is associated with Gibson-Stephens Neuropharmaceuticals, Inc., where he continues to advance research in neuropharmaceuticals. His innovative approach has led to the development of compounds that may improve therapeutic outcomes for patients requiring pain relief.

Collaborations

Pelton has collaborated with Victor J. Hruby, a fellow researcher in the field. Their partnership has contributed to the advancement of knowledge and technology in neuropharmaceuticals.

Conclusion

John T. Pelton's work exemplifies the importance of innovation in the pharmaceutical industry, particularly in developing targeted therapies for pain management. His contributions continue to influence the field and pave the way for future advancements.